B
BiomX Inc. (PHGE)
ASE – Real Time Price. Currency in USD
0.15
-0.01 (-4.16%)
Market open: Aug 12, 2026, 11:03 AM EDT
0.16
-0.00 (-2.08%)
Previous after-hours: Aug 11, 2026, 7:48 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.15
-0.01 (-4.16%)
Market open: Aug 12, 2026, 11:03 AM EDT
0.16
-0.00 (-2.08%)
Previous after-hours: Aug 11, 2026, 7:48 PM EDT
BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company’s phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.
| Name | Position |
|---|---|
| Dr. Carl R. Merril M.D. | Scientific Founder |
| Dr. Eran Elinav M.D., Ph.D. | Scientific Founder |
| Dr. Timothy K. Lu M.D., Ph.D. | Scientific Founder |
| Mr. David Rokach | CFO, Principal Financial Officer & Principal Accounting Officer |
| Mr. Michael Oster | CEO & Director |
| Mr. Roy Timor-Rousso | Chief Business Officer |
| Ms. Marina Wolfson CPA | Secretary |
| Prof. Rotem Sorek Ph.D. | Scientific Founder |
| Date | Type | Document |
|---|---|---|
| 2026-07-28 | 8-K | ea0299423-8k_biomx.htm |
| 2026-07-17 | PRE 14A | ea0297811-pre14a_biomx.htm |
| 2026-07-10 | 8-K | ea0297633-8k_biomx.htm |
| 2026-07-02 | 8-K | ea0296934-8k_biomx.htm |
| 2026-06-30 | S-8 | ea0296467-s8_biomx.htm |
| 2026-06-29 | S-1 | ea0295800-s1_biomx.htm |
| 2026-06-26 | 8-K | ea0296083-8k_biomx.htm |
| 2026-06-22 | DEFA14A | ea0295528-defa14a_biomx.htm |
| 2026-06-18 | 8-K | ea0295251-8k_biomx.htm |
| 2026-06-12 | 8-K/A | ea0293407-8ka1_biomx.htm |